These anti-cancer effects of TNFα may be inhibited by cellular inhibitor of apoptosis proteins (cIAPs), that can inhibit cell death pathway components, as well as promote the activation of transcription factor Nuclear Factor-kappaB (NFκB), that can further induce the expression of IAPs and other pro-survival proteins. Here, NFKB1 is linked to cancer.